Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1810, Issue 8, 2011, Pages 759-768

  Zhang, Lan ^a   Wang, Yinan ^a   Wang, Li ^a,d   Cao, Ting ^a,e   Hyuga, Sumiko ^b   Sato, Toshinori ^c   Wu, Yingliang ^a   Yamagata, Sadako ^a   Yamagata, Tatsuya ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b KITASATO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d RIKEN   (Japan)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Caveolin 1; FBJ cells; Ganglioside GD1a; Hepatocyte growth factor; MET; Metastasis; Osteosarcoma

Indexed keywords

CAVEOLIN 1; GANGLIOSIDE GD 1A; GANGLIOSIDE GD2; GANGLIOSIDE GM2; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLIN 1; CELL LINE, TUMOR; GANGLIOSIDES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; MICE; MICE, INBRED BALB C; N-ACETYLGALACTOSAMINYLTRANSFERASES; OSTEOSARCOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET;

MURINAE;

EID: 79959905761     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.04.006     Document Type: Article

References (36)

1. T. Nakamura, T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu Molecular cloning and expression of human hepatocyte growth factor Nature 342 1989 440 443 (Pubitemid 19277521)
2. R. Zarnegar, and G.K. Michalopoulos The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis J. Cell Biol. 129 1995 1177 1180
3. K. Matsumoto, and T. Nakamura Emerging multipotent aspects of hepatocyte growth factor J. Biochem. 119 1996 591 600 (Pubitemid 26131762)
4. P.M. Comoglio, and L. Trusolino Invasive growth: from development to metastasis J. Clin. Invest. 109 2002 857 862 (Pubitemid 34275105)
5. A. Danilkovitch-Miagkova, and B. Zbar Dysregulation of Met receptor tyrosine kinase activity in invasive tumors J. Clin. Invest. 109 2002 863 867 (Pubitemid 34275106)
6. C. Birchmeier, W. Birchmeier, E. Gherardi, and G.F. Vande Woude Met, metastasis, motility and more Nature Rev. Mol. Cell Biol. 4 2003 915 925 (Pubitemid 37493640)
7. D.P. Bottaro, J.S. Rubin, D.L. Faletto, A.M. Chan, T.E. Kmiecik, G.F. Vande Woude, and S.A. Aaronson Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product Science 251 1991 802 804 (Pubitemid 21926175)
8. M. Stoker, E. Gherardi, M. Perryman, and J. Gray Scatter factor is a fibroblast-derived modulator of epithelial cell mobility Nature 327 1987 239 242 (Pubitemid 17071053)
9. K.G. Rothberg, J.E. Heuser, W.C. Donzell, Y. Ying, J.R. Glenney, and R.G.W. Anderson Caveolin, a protein component of caveolae membrane coats Cell 68 1992 673 682
10. P.E. Scherer, T. Okamoto, M. Chun, I. Nishimoto, H.F. Lodish, and M.P. Lisanti Identification, sequence, and expression of caveolin-2 defines a caveolin gene family Proc. Natl. Acad. Sci. 93 1996 131 135 (Pubitemid 26041482)
11. Z.P. Tang, P.E. Scherer, T. Okamoto, K. Song, C. Chu, D.S. Kohtz, I. Nishimoto, H.F. Lodish, and M.P. Lisanti Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle J. Biol. Chem. 271 1996 2255 2261 (Pubitemid 26047818)
12. E.J. Smart, G.A. Graf, M.A. McNiven, W.C. Sessa, J.A. Engelman, P.E. Scherer, T. Okamoto, and M.P. Lisanti Caveolins, liquid-ordered domains, and signal transduction Mol. Cell. Biol. 19 1999 7289 7304 (Pubitemid 29493393)
13. W.M. Krajewska, and I. Masowska Caveolins: structure and function in signal transduction Cell. Mol. Biol. Lett. 9 2004 195 220 (Pubitemid 38902217)
14. A. Navarro, B. Anad-Apte, and M.O. Parat A role for caveolae in cell migration FASEB J. 18 2004 1801 1811 (Pubitemid 39602266)
15. L. Cantiani, M.C. Manara, C. Zucchini, P. De Sanctis, M. Zuntini, L. Valvassori, M. Serra, M. Olivero, M.F. Di Renzo, M.P. Colombo, P. Picci, and K. Scotlandi Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling Cancer Res. 67 2007 7675 7685 (Pubitemid 47281360)
16. J. Hu, S. Shao, Y. Song, J. Zhao, Y. Dong, L. Gong, and P. Yang Hepatocyte growth factor induces invasion and migration of ovarian cancer cells by decreasing the expression of E-cadherin, beta-catenin, and caveolin-1 Anat. Rec. 293 2010 1134 1139
17. S. Hakomori Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism Cancer Res. 56 1996 5309 5318 (Pubitemid 27011703)
18. S. Hyuga, S. Yamagata, T. Tai, and T. Yamagata Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells Biochem. Biophys. Res. Commun. 231 1997 340 343 (Pubitemid 27214308)
19. S. Hyuga, S. Yamagata, Y. Takatsu, M. Hyuga, H. Nakanishi, K. Furukawa, and T. Yamagata Suppression by ganglioside GD1A of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells Intl. J. Cancer 83 1999 685 691 (Pubitemid 29508051)
20. L. Wang, S. Takaku, P. Wang, D. Hu, S. Hyuga, T. Sato, S. Yamagata, and T. Yamagata Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content Glycoconj. J. 23 2006 303 315 (Pubitemid 44198255)
21. D. Hu, Z. Man, P. Wang, X. Tan, S. Takaku, S. Hyuga, T. Sato, X. Yao, S. Yamagata, and T. Yamagata Ganglioside GD1a negatively regulates matrix metalloproteinase-9 expression in mouse FBJ cell lines at the transcriptional level Connect. Tissue Res. 48 2007 198 205 (Pubitemid 47189883)
22. L. Wang, Y. Wang, T. Sato, S. Yamagata, and T. Yamagata Ganglioside GD1a suppresses TNFα expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells Biochem. Biophys. Res. Commun. 371 2008 230 235
23. T. Cao, T. Zhang, L. Wang, L. Zhang, T. Adachi, T. Sato, S. Yamagata, and T. Yamagata Ganglioside GD1a suppression of NOS2 expression via ERK1 pathway in mouse osteosarcoma FBJ cells J. Cell. Biochem. 110 2010 1165 1174
24. S. Hyuga, N. Kawasaki, M. Hyuga, M. Ohta, R. Shibayama, T. Kawanishi, S. Yamagata, T. Yamagata, and T. Hayakawa Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met Intl. J. Cancer 94 2001 328 334 (Pubitemid 32906061)
25. S. Yamagata, Y. Ito, R. Tanaka, and S. Shimizu Gelatinase of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis Biochem. Biophys. Res. Commun. 151 1988 158 162 (Pubitemid 18074157)
26. P. Wang, P. Wu, J. Zhang, T. Sato, S. Yamagata, and T. Yamagata Positive regulation of tumor necrosis factor alpha by ganglioside GM3 through Akt in mouse melanoma B16 cells Biochem. Biophys. Res. Commun. 356 2007 438 443 (Pubitemid 46452565)
27. E.G. Bremer, J. Schlessinger, and S. Hakomori Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor J. Biol. Chem. 261 1986 2434 2440 (Pubitemid 17205183)
28. N. Kawashima, S.J. Yoon, K. Itoh, and K. Nakayama Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions J. Biol. Chem. 284 2009 6147 6155
29. X. Wang, P. Sun, A. Al-Qamari, T. Tai, I. Kawashima, and A.S. Paller Carbohydrate-carbohydrate binding of ganglioside to integrin alpha(5) modulates alpha(5)beta(1) function J. Biol. Chem. 276 2001 8436 8444
30. K. Mitsuzuka, K. Handa, M. Satoh, Y. Arai, and S. Hakomori A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9 J. Biol. Chem. 280 2005 35545-34453
31. A.R. Todeschini, J.N. Dos Santos, K. Handa, and S.I. Hakomori Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse J. Biol. Chem. 282 2007 8123 8133 (Pubitemid 47093583)
32. A. Prinetti, M. Aureli, G. Illuzzi, S. Prioni, V. Nocco, F. Scandroglio, N. Gagliano, G. Tredici, V. Rodriguez-Menendez, V. Chigorno, and S. Sonnino GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells Glycobiology 20 2010 62 77
33. H. Nojiri, F. Takaku, Y. Terui, Y. Miura, and M. Saito Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937 Proc. Natl. Acad. Sci. 83 1986 782 786 (Pubitemid 16035559)
34. S. Tsuji, M. Arita, and Y. Nagai GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines J. Biochem. 94 1983 303 306 (Pubitemid 13046116)
35. T.M. Williams, G.S. Hassan, J. Li, A.W. Cohen, F. Medina, P.G. Frank, R.G. Pestell, D. Di Vizio, M. Loda, and M.P. Lisanti Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice J. Biol. Chem. 280 2005 25134 25145 (Pubitemid 40934606)
36. T.M. Williams, and M.P. Lisanti The caveolin proteins Genome Biol. 5 2004 214